Intestinal Microbiota in Stem Cell Transplant Transplant Admission

Description

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.

Conditions

Stem Cell Transplant Complications

Study Overview

Study Details

Study overview

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.

Intestinal Microbiota Alteration by Antibiotics Used During Stem Cell Transplant Admission

Intestinal Microbiota in Stem Cell Transplant Transplant Admission

Condition
Stem Cell Transplant Complications
Intervention / Treatment

-

Contacts and Locations

Detroit

Henry Ford Health System, Detroit, Michigan, United States, 48202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients aged 18-80 years
  • * patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Henry Ford Health System,

shatha farhan, PRINCIPAL_INVESTIGATOR, Henry Ford

Study Record Dates

2026-11-03